ICICI Securities has given a buy rating to Natco Pharma with a target price of Rs 954. The share price moved up by 17.69% from its previous close of Rs 776.45. The stock's last traded price is Rs 913.80. 

Natco Pharma Ltd., incorporated in the year 1981, is a Midcap company operating in the Pharmaceuticals sector.

Financials 
For the quarter ended 30-06-2020, the company has reported consolidated sales of Rs 563.40 crore, up 23.88% from last quarter sales of Rs 454.80 crore and up 14.44% from the last year same quarter sales of Rs 492.30 crore. The company reported net profit after tax of Rs 122.10 crore in the latest quarter.

Promotors/FII Holdings
Promotors held a 48.9% stake in the company as of June 30, 2020, while FIIs held 24.4%, DIIs 8.9%, and public & others 17.8%.